HRA005516
Title:
A Proteogenomic Analysis of Cervical Cancer in East Asia Reveals Biological Insights and Therapeutic Signatures
Release date:
2024-10-08
Description:
Cervical cancer remains the fourth most common malignancy and the fourth leading cause of cancer mortality in women. Unlike many other cancers lacking direct etiological association with virus infection, persistent human papillomavirus infection is the central cause of CC, and over 90% of CC patients are associated with HPV infection at the time of diagnosis. There is an urgent need in clinical practice to enhance the efficacy of radiotherapy for advanced patients. Investigating the molecular mechanism of CC development and its HPV association and identifying candidate biomarkers or therapeutic targets could improve individualized diagnosis and therapy for CC, which would greatly improve patient survival and quality of life.
Data Accessibility:   
Controlled access Request Data
BioProject:
Study type:
Disease Study
Disease name:
cervix carcinoma
Data Access Committee

For each controlled access study, there is a corresponding Data Access Committee(DAC) to determine the access permissions. Access to actual data files is not managed by NGDC.


DAC NO.:
DAC name:
Cervical Cancer
Contact person:
Yu Jing
Email:
17611768237@126.com
Description:
A Proteogenomic Analysis of Cervical Cancer in East Asia Reveals Biological Insights and Therapeutic Signatures
Individuals & samples
Submitter:   Zhou Hu / zhouhu@simm.ac.cn
Organization:   Shanghai Institute of Materia Medica
Submission date:   2023-09-06
Requests:   13